miércoles , 27 octubre 2021
Ultima hora
Inicio / BIBLIOGRAFIA / Rehabilitation and COVID-19: the Cochrane Rehabilitation 2020 rapid living systematic review

Rehabilitation and COVID-19: the Cochrane Rehabilitation 2020 rapid living systematic review

European Journal of Physical and Rehabilitation Medicine 2020 October;56(5):642-51

Maria G. CERAVOLO , Chiara ARIENTI , Alessandro de SIRE , Elisa ANDRENELLI , Francesco NEGRINI , Stefano G. LAZZARINI, Michele PATRINI , Stefano NEGRINI

INTRODUCTION: This paper improves the methodology of the first edition of the rapid living systematic review started in April 2020, with the aim to gather and present the current evidence informing rehabilitation of patients with COVID-19 and/or describing the consequences due to the disease and its treatment.

EVIDENCE ACQUISITION: The Cochrane methodology for a rapid living systematic review was applied. Primary research papers, published from 1 January to 30 June 2020, reporting patients’ data, with no limits of study design were included. Studies were categorized for study design, research question, COVID-19 phase, limitations of functioning (disability) of rehabilitation interest and type of rehabilitation service involved. Methodological quality assessment was based on the Cochrane Risk of Bias tools, and the level of evidence table (OCEBM 2011) for all the other studies.

EVIDENCE SYNTHESIS: Thirty-six, out of 3703 papers, were included. One paper was of level 2 (RCT), 7 were of level 3 (2 cohort studies, 2 cross-sectional studies and 3 case-control studies), and 28 papers of level 4 (descriptive studies); 61% of papers reported epidemiological data on clinical presentations, 5 investigated natural history/determining factors, 1 searched prevalence, 2 studies reported on intervention efficacy (though not on harms), and 5 studies looked at health service organization.

CONCLUSIONS: Main issues emerging from the review: it is advised to test for COVID-19 people with neurological disorders presenting with symptom changes; dysphagia is a frequent complication after oro-tracheal intubation in COVID-19 patients admitted to the ICU; after discharge, COVID-19 survivors may report persistent restrictive ventilatory deficits regardless of disease severity; there is only sparse and low quality evidence concerning the efficacy of any rehabilitation intervention to promote functional recovery; a substantial increase in resource (staff and equipment) is needed for rehabilitation.

Sobre Aritz Monasterio

Interesante también

Vacuna Covid-19 de Moderna: segura, eficaz y con efectos leves en niños de seis a once años

La compañía Moderna ha afirmado este lunes que su vacuna contra la Covid-19 genera una respuesta inmune fuerte en niños de ...

Deja un comentario